On Tuesday, December 5, 2023, Worldwide Diabetes will present the live virtual symposium “Harnessing the Power of AI to Help Eliminate Preventable Blindness” in partnership with IDF Virtual Congress 2023.

Diabetic retinopathy is a complication of diabetes, caused by damage to blood vessels in the eyes. It affects approximately 30 percent of persons with diabetes and is one of the most prevalent eye afflictions in existence today. Recently, significant advances in diabetic retinopathy screening have been made, with the use of artificial intelligence (AI) technology. This ground-breaking technology is noninvasive and extremely accurate, especially compared to visual methods. This satellite symposium will discuss the evolution of eye screening technology, the new science of AI screening, and provide health care professionals with data regarding AI screening and how it can impact clinical practice.

In order to participate in this virtual symposium, one must register for the overall IDF Virtual Congress. To register, please visit https://idf2023.org/registration/. Upon the conclusion of the Congress, the symposium will be available on-demand via the Congress website as well as on this site.

Click here to view the symposium faculty and agenda in full detail.

On Wednesday, December 6, 2023, Worldwide Diabetes will present the live virtual symposium “What’s New in MASLD: A Diagnosis and Management Update for the Busy Clinician” in partnership with IDF Virtual Congress 2023.

Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD, formerly known as NAFLD) has become an epidemic, much like other non-communicable diseases (NCDs), such as cancer, obesity, diabetes, and cardiovascular disease. Patients at the greatest risk are those with obesity and type 2 diabetes mellitus. Thus, it is important to understand to what extent diabetes increases the risk of severe forms of MASLD and whether this risk is independent of or possibly additive to other cardiometabolic risk factors. This program will provide an increased understanding of why MASLD/MASH is affecting a significant percentage of people with diabetes, clear direction on the key diagnostic steps for MASLD that will lead to better patient management, and guidelines on treatments that have been shown to be effective.

In order to participate in this virtual symposium, one must register for the overall IDF Virtual Congress. To register, please visit https://idf2023.org/registration/. Upon the conclusion of the Congress, the symposium will be available on-demand via the Congress website as well as on this site.

Click here to view the symposium faculty and agenda in full detail.